Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Par Pharmaceutical Companies, Inc.
WOODCLIFF LAKE, N.J., Oct. 24, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. is proud to announce that Karen O'Connor, vice president, national accounts, has received the generic pharmaceutical manufacturer 2013 Cardinal Health Supply Chain Excellence Award. The award was presented today at Cardinal's annual Business Partners Conference in Columbus, Ohio.
The Cardinal Health Supply Chain Excellence Award recipient is judged across a variety of metrics specifically targeted at the importance of Cardinal's generic pharmaceutical manufacturer partners. These metrics recognize actions taken by generic suppliers to enhance service levels and create efficiencies in the supply chain, including execution on new product launches.
"It is especially gratifying to receive an award from a highly-valued strategic partner," said Renee Kenney, senior vice president generic sales for Par Pharmaceutical. "Both Karen and Par are honored to be recognized by Cardinal Health for our unwavering commitment to customer service. Our efforts underscore the importance of this partnership to Par and we are proud of the trust and confidence that Cardinal has placed in us."
Ms. O'Connor has been responsible for managing the company's relationship with Cardinal Health since joining Par in 2007.
About Par Pharmaceutical Companies, Inc. Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. For press release and other company information, visit www.parpharm.com.